Intellectual Property Office
class="gem-c-govspeak govuk-govspeak govuk-!-margin-bottom-0">
In the table below we provide you with information about applications we have received to amend the specification of a patent under sections 27 and 75 before the court and the Office. The table also includes information about when you need to file an opposition if you wish to oppose the application to amend.
Where amendments have been filed electronically, you can obtain full details by selecting the patent number. If you are the patent owner(s), you should check these details carefully and inform us if there are any problems. Where amendments have been filed in paper form only, the symbol * appears in the table after the patent number.
In the case of amendments filed under section 75 before the court and under section 27 at the Office, reasons for the amendments are also provided.
You can obtain reasons for the amendments and full details of any amendments filed in paper form by contacting Litigation Section (telephone: +44 (0)1633 814334).
Opposition procedures
Section 75 before the court
If you want to oppose an amendment filed under section 75 before the court, you need to file a notice of opposition at the court. In the notice you need to set out clearly your reasons for opposing the amendment. You need to send us a copy of the notice and send a copy to anyone involved in the court proceedings. You need to do this within 14 days of the advertisement on our web site of the application to amend.
Section 75 before the comptroller and section 27 amendments
If you want to oppose an amendment filed under section 75 before the comptroller or an amendment filed under section 27, you need to complete and send us:
- 2 copies of form 15 with the fee of 50. You will need to pay a further fee of 350 later
- 2 copies of a statement setting out fully the facts of your case and what you want us to do
Opposition table 2024
Section | Patents Journal | Deadline for filing opposition | Patent number and title | International Classification | Proprietor, including court action number (if any) and address for service |
---|---|---|---|---|---|
75 Before the Court | 7075 25 December 2024 | 14 days | Subcutaneous Anti-Her2 Antibody Formulation | A61K | F. Hoffmann-La Roche AG HP-2024-000003 Herbert Smith Freehills LLP Exchange House Primrose Street London EC2A 2EG |
75 Before the Court | 7074 18 December 2024 | 14 days | Vegf Antagonist Formulations Suitable for Intravitreal Administration | A61K | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA |
75 Before the Court | 7074 18 December 2024 | 14 days | Vegf Antagonist Formulations Suitable for Intravitreal Administration | A61K | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA |
75 Before the Court | 7070 20 November 2024 | 14 days | VEGF Antagonist formulations suitable for intravitreal administration | A61K | Regeneron Pharmaceuticals, Inc. HP-2024-000015, HP-2024-000035, HP-2024-000036 Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA |
75 Before the Court | 7066 23 October 2024 | 14 days | C-ARYL glucoside SGLT2 inhibitors and method | C07H | Astra Zeneca AB HP-2023-000035 HP-2023-000040 HP-2023-000046 Freshfields Bruckhaus Deringer LLP 100 Bishopsgate London EC2P 2SR |
27 | 7063 2 October 2024 | 4 weeks | Method and composition for producing enhanced anti-inflammatory/anti-catabolic and regenerative agents from autoglogous physiological fluid | A61K | Antnor Limited |
27 | 7060 11 September 2024 | 4 weeks | Axial field rotary energy device with segmented PCB stator having thermally conductive layer | H02K | Infinitum Electric, Inc |
27 | 7055 7 August 2024 | 4 weeks | A stand-up inflatable paddle board | B63B | Red Paddle Co Limited |
27 | 7050 3 July 2024 | 4 weeks | Secure distributed execution of jobs | G06F | Mobileye Vision Technologies Ltd |
27 | 7049 26 June 2024 | 4 weeks |